Navigation Links
Spanish Health Service Provider Selects Autonomy to Deliver Innovation Within Healthcare
Date:7/8/2008

Pan-Enterprise Search Platform to Improve Quality of Patient Data System

CAMBRIDGE, England and SAN FRANCISCO, July 8 /PRNewswire-FirstCall/ -- Autonomy Corporation plc (LSE: AU. or AU.L), a global leader in infrastructure software for the enterprise, today announced that Servicio Extremeno de Salud (SES), a provider of public healthcare services to the one million inhabitants of the Extremadura region of Spain, has selected Autonomy's Meaning-based Computing solution to quickly and accurately provide alerts on patient prescription conflicts as part of a national project, entitled "JARA", to modernise Spanish healthcare.

The new system powered by Autonomy's Intelligent Data Operating Layer (IDOL), will automatically ingest all of the patients' information, including age, allergies, previous illnesses, etc, so that when doctors prescribe medication, the pharmacists can use the system to assess whether there will be any complications with the prescription. This eliminates the costs and time associated with manually examining each patient's potential prescription conflicts. With Autonomy, SES aims to provide a more efficient and improved regional healthcare system.

"We are always looking for new ways to improve our patient care and having the right technology is very important," commented Francisco Luis Caceres, Coordinator of SES "JARA" project. "Autonomy's innovative software will help eliminate the potential risks within the prescription process by proactively sending alerts to medical staff without the need to perform manual searches or checks. This will help our doctors and pharmacists to work more efficiently."

"We are delighted to deliver innovative technology to benefit the healthcare industry," said Mike Lynch, CEO of Autonomy. "It is an honor to know that our technology will be used to improve the efficiency of healthcare professionals and enable a higher level of medical care."

About Servicio Extremeno de Salud (SES) <
'/>"/>

SOURCE Autonomy Corporation plc
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. New Spanish Consumer Guide Compares Diabetes Meds
2. New Spanish-Language Consumer Guide Compares Oral Diabetes Medications
3. Premier Web Site on Child and Teen Mental Health Now in Spanish
4. Child obesity seen as fueled by Spanish language tv ads
5. USP publishes Spanish edition of United States Pharmacopeia and National Formulary
6. USP Publishes Spanish Edition of United States Pharmacopeia and National Formulary
7. Gerresheimer Finalises Purchase of Spanish Company EDP
8. NINDS Announces New Spanish-Language Website
9. Latin American adolescents are more likely to become infected with HIV than Spanish
10. In Honor of Hispanic Heritage Month and Spanish Speakers Worldwide International Hyperhidrosis Society Publishes Important New Patient Booklet in Spanish
11. Members of consumer-driven health plans choosing less care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...ubstantially higher rates of mental health problem...s from a systematic review and meta-analysis publi...or studies over the past four decades containing d...ess people, Seena Fazel and colleagues of the Univ...,684 homeless individuals based in the US, UK, mai...
(Date:12/2/2008)...mposium today hosted by Johns,Hopkins University...s presented,the latest research in brain plastici... into technology to improve lives. Henry Mahncke, ...e that cognitive intervention developed by,Posit ...s ability to,reorganize itself throughout life. ...
(Date:12/2/2008)... assault are unsettling; the Department of Justice...e victim of attempted or actual sexual assault dur...rs from two universities, including the University...are unaware of drug-facilitated sexual assault and...including leaving drinks unattended. , "These f...
(Date:12/2/2008)...rprise software and online services veteran is exp...ers of Yugma,s instant web conferencing solutions ... December 2, 2008 -- Yugma , the leading web conf...aborate instantly using the Internet, announced th... Officer. , , ,Vas has more than 20 years of exper...
Breaking Medicine News(10 mins):Health News:Posit Science Invited to Speak at Johns Hopkins University About Cutting Edge Cognitive Training Interventions 2Health News:MU researcher calls for increase in sexual assault awareness programs on college campuses 2Health News:MU researcher calls for increase in sexual assault awareness programs on college campuses 3Health News:Yugma Appoints Vas Bhandarkar as Chief Executive Officer 2Health News:Yugma Appoints Vas Bhandarkar as Chief Executive Officer 3
... have said in the British Medical Journal that the...tals since 1990, based on mythical safety risks, a...phones were banned in hospitals after fears of the...and to prevent the potential confusion between the...
...ar 500,000 Americans develop pneumococcal pneumoni... serious, possibly fatal, illness. The October iss...g the word: A vaccine is available that helps prot...pneumonia and reduces the serious complications of...
... with allergic symptoms like wheezing, asthma, ha...nsitization to their infants too, according to a s...ts that the current practice of avoiding skin test... 4 or 5 should be reconsidered, so children in thi...
... a clear indication in a scientific journal regard...ing clinical trial//, the drug was tested on human...re drug reaction. But for the timely emergency car...ve been history. A Dutch report documenting the ...
Other Medicine News:Health News:Allergy Sufferers Pass on Allergies to their Children 2
(Date:12/1/2008)...wire-USNewswire/ -- A study has found that positro...imaging the breast, is not affected by either brea...rs that limit the effectiveness of standard mammog... presented today at the annual meeting of the Radi..., "The ability of PEM to detect cancer does not ...
(Date:12/1/2008)...ith ENB-0040 at Children,s Hospital, Health Scienc... Enobia Pharma, an emerging Canadia...apeutics for serious bone disorders, today announc...rogram for hypophosphatasia was dosed. Enobia is i... ENB-0040 for the treatment of this rare and often...
(Date:12/1/2008)... December 9 at 11:00 am ET to Discuss Phase 2 Stud...O, Calif., Dec. 1 Sune...pharmaceutical company focused on the development ..., today announced new data from its studies of vor...sented during the 50th American Society of Hematol...
(Date:11/28/2008)...swire/ -- German biotech company,Partec is expand...oring and,AIDS patient follow-up diagnostics for ...08, 2.5 million patient tests have been performed ...CyFlow" system, supporting already,more than 1 mi...tion of the,Partec innovation, the average cost o...
Breaking Medicine Technology:New Mammography Technology Effective in Detecting Breast Cancer 2New Mammography Technology Effective in Detecting Breast Cancer 3New Mammography Technology Effective in Detecting Breast Cancer 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2Medifast Adds New Crunchy Bars to Product Line 28861 1Medifast Adds New Crunchy Bars to Product Line 28861 2NCPA Statement on November 4th Election Results 28860 1NCPA Statement on November 4th Election Results 28860 2ConjuChem Provides Development Update 8911 1ConjuChem Provides Development Update 8911 2ConjuChem Provides Development Update 8911 3State fund advances titanium powder research 9 other Iowa State projects 5736 1State fund advances titanium powder research 9 other Iowa State projects 5736 2State fund advances titanium powder research 9 other Iowa State projects 5736 3State fund advances titanium powder research 9 other Iowa State projects 5736 4
BD Vacutainer® PST™ Tubes contain spray-coated lithium heparin and a gel for plasma separation. They are used for plasma determinations in chemistry.
MONOJECT Red/Yellow Mottled Stopper
BD Vacutainer® Specialty Tubes - Thrombin
BD Vacutainer® PST™ Tubes contain spray-coated lithium heparin and a gel for plasma separation. They are used for plasma determinations in chemistry.
Medicine Products: